LMR Partners LLP Invests $2.16 Million in Surgery Partners, Inc. (NASDAQ:SGRY)

LMR Partners LLP acquired a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 101,800 shares of the company's stock, valued at approximately $2,155,000. LMR Partners LLP owned approximately 0.08% of Surgery Partners as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in SGRY. Franklin Resources Inc. raised its position in Surgery Partners by 19.5% in the 3rd quarter. Franklin Resources Inc. now owns 21,324 shares of the company's stock worth $677,000 after purchasing an additional 3,487 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Surgery Partners by 3.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 189,436 shares of the company's stock valued at $6,107,000 after purchasing an additional 5,551 shares in the last quarter. Inspire Investing LLC boosted its stake in shares of Surgery Partners by 47.5% during the 4th quarter. Inspire Investing LLC now owns 19,034 shares of the company's stock valued at $403,000 after purchasing an additional 6,131 shares in the last quarter. KBC Group NV boosted its stake in Surgery Partners by 66.1% during the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after acquiring an additional 1,577 shares in the last quarter. Finally, E. Ohman J or Asset Management AB boosted its stake in Surgery Partners by 40.3% during the fourth quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company's stock worth $26,317,000 after acquiring an additional 357,023 shares in the last quarter.

Insider Activity at Surgery Partners

In other Surgery Partners news, CFO David T. Doherty sold 6,733 shares of Surgery Partners stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the completion of the transaction, the chief financial officer now directly owns 150,868 shares of the company's stock, valued at $3,623,849.36. This trade represents a 4.27% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the transaction, the insider now directly owns 63,408 shares of the company's stock, valued at $1,527,498.72. The trade was a 4.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

SGRY has been the subject of several recent analyst reports. Macquarie decreased their target price on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a report on Tuesday, March 11th. Royal Bank of Canada reiterated an "outperform" rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Tuesday, March 25th. Finally, Benchmark reiterated a "buy" rating and issued a $35.00 price target on shares of Surgery Partners in a research report on Monday, April 21st. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Surgery Partners presently has an average rating of "Moderate Buy" and a consensus price target of $34.75.

Surgery Partners Price Performance

SGRY traded up $0.30 during trading on Friday, hitting $23.94. 962,649 shares of the company traded hands, compared to its average volume of 1,091,189. The company has a market cap of $3.07 billion, a PE ratio of -49.88, a P/E/G ratio of 19.21 and a beta of 1.96. The stock's 50-day simple moving average is $22.55 and its two-hundred day simple moving average is $23.23. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $33.97. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.04). The company had revenue of $776.00 million for the quarter, compared to analysts' expectations of $777.77 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business's revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.10 earnings per share. As a group, sell-side analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.